
Misook Yu
Supervisory Patent Examiner (ID: 13848, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 878 |
| Issued Applications | 268 |
| Pending Applications | 204 |
| Abandoned Applications | 408 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5022213
[patent_doc_number] => 20070148179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Gankyrin'
[patent_app_type] => utility
[patent_app_number] => 11/702119
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19130
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148179.pdf
[firstpage_image] =>[orig_patent_app_number] => 11702119
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/702119 | Gankyrin | Feb 4, 2007 | Abandoned |
Array
(
[id] => 202331
[patent_doc_number] => 07632650
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-15
[patent_title] => 'Diagnostics and therapeutic uses of topors'
[patent_app_type] => utility
[patent_app_number] => 11/671041
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 7193
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/632/07632650.pdf
[firstpage_image] =>[orig_patent_app_number] => 11671041
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/671041 | Diagnostics and therapeutic uses of topors | Feb 4, 2007 | Issued |
Array
(
[id] => 4734579
[patent_doc_number] => 20080051559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'MT-SP1 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/669725
[patent_app_country] => US
[patent_app_date] => 2007-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 35995
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051559.pdf
[firstpage_image] =>[orig_patent_app_number] => 11669725
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/669725 | MT-SP1 polypeptides | Jan 30, 2007 | Abandoned |
Array
(
[id] => 5159443
[patent_doc_number] => 20070172487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Alpha-enolase specific antibody and method of use'
[patent_app_type] => utility
[patent_app_number] => 11/648132
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14446
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172487.pdf
[firstpage_image] =>[orig_patent_app_number] => 11648132
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/648132 | Alpha-enolase specific antibody and method of use | Dec 28, 2006 | Issued |
Array
(
[id] => 5252797
[patent_doc_number] => 20070134253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Novel serpentine transmembrane antigens expressed in human cancers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/647988
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 22302
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134253.pdf
[firstpage_image] =>[orig_patent_app_number] => 11647988
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/647988 | Novel serpentine transmembrane antigens expressed in human cancers and uses thereof | Dec 28, 2006 | Abandoned |
Array
(
[id] => 4915164
[patent_doc_number] => 20080095764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Use of genetically-and epigenetically-altered protocadherins in methods of diagnosing, prognosing, and treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/637277
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 23520
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20080095764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11637277
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/637277 | Use of genetically-and epigenetically-altered protocadherins in methods of diagnosing, prognosing, and treating cancer | Dec 11, 2006 | Abandoned |
Array
(
[id] => 190759
[patent_doc_number] => 07642070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-05
[patent_title] => 'Tumor suppressor gene'
[patent_app_type] => utility
[patent_app_number] => 11/603619
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 15516
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/642/07642070.pdf
[firstpage_image] =>[orig_patent_app_number] => 11603619
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/603619 | Tumor suppressor gene | Nov 21, 2006 | Issued |
Array
(
[id] => 5136459
[patent_doc_number] => 20070078088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480, 20893, 33230, 1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules'
[patent_app_type] => utility
[patent_app_number] => 11/603696
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82163
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20070078088.pdf
[firstpage_image] =>[orig_patent_app_number] => 11603696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/603696 | Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480, 20893, 33230, 1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules | Nov 21, 2006 | Abandoned |
Array
(
[id] => 5106573
[patent_doc_number] => 20070065450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Snail, a new marker for tumour invasion and target protein of new antitumoral compounds'
[patent_app_type] => utility
[patent_app_number] => 11/599664
[patent_app_country] => US
[patent_app_date] => 2006-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5011
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065450.pdf
[firstpage_image] =>[orig_patent_app_number] => 11599664
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/599664 | Snail, a new marker for tumour invasion and target protein of new antitumoral compounds | Nov 14, 2006 | Issued |
Array
(
[id] => 4657120
[patent_doc_number] => 20080025981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Cancer-linked genes as targets for chemotherapy'
[patent_app_type] => utility
[patent_app_number] => 11/599845
[patent_app_country] => US
[patent_app_date] => 2006-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21580
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20080025981.pdf
[firstpage_image] =>[orig_patent_app_number] => 11599845
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/599845 | Cancer-linked genes as targets for chemotherapy | Nov 14, 2006 | Abandoned |
Array
(
[id] => 363321
[patent_doc_number] => 07482131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-27
[patent_title] => 'Detection of PKC-iota as a biomarker for brain tumorigenesis'
[patent_app_type] => utility
[patent_app_number] => 11/560030
[patent_app_country] => US
[patent_app_date] => 2006-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5320
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/482/07482131.pdf
[firstpage_image] =>[orig_patent_app_number] => 11560030
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/560030 | Detection of PKC-iota as a biomarker for brain tumorigenesis | Nov 14, 2006 | Issued |
Array
(
[id] => 5187988
[patent_doc_number] => 20070166296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Therapeutic Systems'
[patent_app_type] => utility
[patent_app_number] => 11/558042
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20166
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166296.pdf
[firstpage_image] =>[orig_patent_app_number] => 11558042
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/558042 | Therapeutic Systems | Nov 8, 2006 | Abandoned |
Array
(
[id] => 170267
[patent_doc_number] => 07662580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Tissue diagnostics for breast cancer'
[patent_app_type] => utility
[patent_app_number] => 11/595298
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14499
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662580.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595298
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595298 | Tissue diagnostics for breast cancer | Nov 8, 2006 | Issued |
Array
(
[id] => 5182545
[patent_doc_number] => 20070053891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Snail, a new marker for tumour invasion and target protein of new antitumoral compounds'
[patent_app_type] => utility
[patent_app_number] => 11/591717
[patent_app_country] => US
[patent_app_date] => 2006-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5011
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053891.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591717
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591717 | Snail, a new marker for tumour invasion and target protein of new antitumoral compounds | Nov 1, 2006 | Abandoned |
Array
(
[id] => 363316
[patent_doc_number] => 07482126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-27
[patent_title] => 'Snail, a new marker for tumour invasion and target protein of new antitumoral compounds'
[patent_app_type] => utility
[patent_app_number] => 11/591825
[patent_app_country] => US
[patent_app_date] => 2006-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 5091
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/482/07482126.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591825 | Snail, a new marker for tumour invasion and target protein of new antitumoral compounds | Nov 1, 2006 | Issued |
Array
(
[id] => 5135961
[patent_doc_number] => 20070077590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Snail, a new marker for tumour invasion and target protein of new antitumoral compounds'
[patent_app_type] => utility
[patent_app_number] => 11/591826
[patent_app_country] => US
[patent_app_date] => 2006-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5056
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077590.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591826
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591826 | Snail, a new marker for tumour invasion and target protein of new antitumoral compounds | Nov 1, 2006 | Abandoned |
Array
(
[id] => 4999813
[patent_doc_number] => 20070042447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Use of anti-ferritin monoclonal antibodies in the treatment of some cancers (divisional)'
[patent_app_type] => utility
[patent_app_number] => 11/589406
[patent_app_country] => US
[patent_app_date] => 2006-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6217
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042447.pdf
[firstpage_image] =>[orig_patent_app_number] => 11589406
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/589406 | Use of anti-ferritin monoclonal antibodies in the treatment of some cancers (divisional) | Oct 29, 2006 | Abandoned |
Array
(
[id] => 5538718
[patent_doc_number] => 20090220523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY AND NEOVASCULARIZATION CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/091890
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24083
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220523.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091890
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091890 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY AND NEOVASCULARIZATION CONDITIONS | Oct 26, 2006 | Abandoned |
Array
(
[id] => 5050894
[patent_doc_number] => 20070031439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Novel protein related to melanoma-inhibiting protein and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/583426
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 41224
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031439.pdf
[firstpage_image] =>[orig_patent_app_number] => 11583426
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/583426 | Novel protein related to melanoma-inhibiting protein and uses thereof | Oct 18, 2006 | Abandoned |
Array
(
[id] => 5215639
[patent_doc_number] => 20070104720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Novel serpentine transmembrane antigens expressed in human cancers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/580538
[patent_app_country] => US
[patent_app_date] => 2006-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 21296
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104720.pdf
[firstpage_image] =>[orig_patent_app_number] => 11580538
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/580538 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Oct 11, 2006 | Issued |